Organon (OGN) Payables (2020 - 2026)

Organon's Payables history runs 7 years deep, the most recent figure standing at $983.0 million for Q1 2026.

• In Q1 2026, Payables fell 2.29% year-over-year to $983.0 million; the TTM figure through Mar 2026 stood at $983.0 million (down 2.29% YoY), while the FY2025 annual figure was $952.0 million, down 17.43% from the prior year.
• Payables was $983.0 million for Q1 2026 at Organon, up from $952.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.3 billion in Q4 2023 to a low of $952.0 million in Q4 2025.
• Historically, Payables has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2025.
• Biggest YoY gain for Payables was 309.47% in 2022; the steepest drop was 38.55% in 2022.
• A 5-year view of Payables shows it stood at $1.1 billion in 2022, then climbed by 16.08% to $1.3 billion in 2023, then retreated by 12.25% to $1.2 billion in 2024, then fell by 17.43% to $952.0 million in 2025, then grew by 3.26% to $983.0 million in 2026.
• The last three Payables figures came in at $983.0 million (Q1 2026), $952.0 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.